COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab™. FecalSwab™ ...

MILAN — Italy’s Copan Group, one of the main manufacturers of swabs globally, has been approached by suitors and would be willing to accept any new investor prepared to support its expansion into new ...

MURRIETA, Calif., May 13 Copan was recently granted the Australian patent for its line of flocked swabs. Copan is the original inventor of flocked swab technology and introduced the first flocked ...

Apple Inc said on Thursday that it was awarding $10 million to a maker of nasal swabs and other materials for collecting samples for Covid-19 tests in a move aimed at boosting the swab maker's ...

MURRIETA, Calif., Dec. 16, 2010 /PRNewswire/ -- COPAN has enjoyed widespread use of its flocked swabs line, branded as FLOQSwabs, in microbiology for the collection and transportation of bacterial and ...

Dublin, March 11, 2022 (GLOBE NEWSWIRE) -- The "Medical Swab Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The medical swab market is ...

The two top makers of the highly specialized swabs used to test patients for the novel coronavirus are straining to keep up with the demand, even as both the Italian and U.S. governments are working ...

Last May, Apple’s Advanced Manufacturing Fund awarded $10 million to COPAN Diagnostics to accelerate its supply of sample kits for hospitals across the U.S., expand production and help the expansion ...

Before COVID-19, Norman Sharples ran a company that was a market leader in a very niche business — supplying nasal swabs collection kits for detecting respiratory viruses such as the flu. Obviously, ...

EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of ...